Unique Aspects of Pancreatic Cancer Proteins Could Lead to Early Detection & New Treatments, Johns Hopkins-Led International Study Published in Cell Suggests

A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins. The new findings, published online on September 16, 2021 in Cell, could offer hope to patients with this deadly disease. The open-access article is titled “Proteogenomic Characterization of Pancreatic Ductal Adenocarcinoma.” “Right now, patients with pancreatic cancer have very few options, and the wealth of data produced by this study could lead to new ways to fight this disease,” says study leader Hui Zhang, PhD, Director of the Mass Spectrometry Core Facility and Professor of Pathology at the Johns Hopkins University School of Medicine.